SCHEMBL7628013

SCHEMBL7628013

CCOc1cccc(C(O)CNC)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 5/20 0.59
ADRB2 P07550 3/20 0.59
ADRB1 P08588 3/20 0.59
ADRA2A P08913 3/20 0.59
ADRB3 P13945 3/20 0.59
ADRA2B P18089 3/20 0.59
ADRA2C P18825 3/20 0.59
TSHR P16473 2/20 0.59
DRD1 P21728 2/20 0.59
ADRA1A P35348 2/20 0.59
ADRA1B P35368 2/20 0.59
DRD3 P35462 2/20 0.59
HTR1A P08908 2/20 0.59
NFKB1 P19838 1/20 0.59
HTR7 P34969 1/20 0.59
RAB9A P51151 1/20 0.59
SLC6A3 Q01959 1/20 0.59
KDM4E B2RXH2 5/20 0.58
BLM P54132 3/20 0.58
LMNA P02545 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11418040 0.98 HIF1A (0.60) HIF1AADRB2ADRB1ADRA2AADRB3
SCHEMBL11824232 0.85 ALOX5 (0.55) HIF1AADRB2ADRB1ADRA2AADRB3
SCHEMBL3070382 0.85 HIF1A (0.56) HIF1AADRB2ADRB1ADRA2AADRB3
SCHEMBL3443108 0.84 AOC3 (0.74) HIF1AADRB2ADRB1ADRA2AADRB3
SCHEMBL22953181 0.84 AOC3 (0.74) HIF1AADRB2ADRB1ADRA2AADRB3
SCHEMBL19647548 0.84 ADRB2 (0.55) HIF1AADRB2ADRB1ADRA2AADRB3
SCHEMBL6055172 0.83 LMNA (0.52) HIF1ATSHRNFKB1KDM4EBLM
Hydrochloric Acid SCHEMBL11755510 0.83 ALOX5 (0.56) HIF1AADRB2ADRB1ADRA2AADRB3
Hydrochloric Acid SCHEMBL6848635 0.83 AOC3 (0.72) HIF1AADRB2ADRB1ADRA2AADRB3
SCHEMBL25159566 0.82 HIF1A (0.57) HIF1AADRB2ADRB1ADRA2AADRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250108056-A1 SUBLINGUAL FORMULATION FOR HYPOTENSION AND SYNCOPE HAMDAN MOHAMED HUSSEIN (US) 2025-04-03 US claimed
EP-4157451-B1 SUBLINGUAL FORMULATION FOR HYPOTENSION AND SYNCOPE HAMDAN MOHAMED HUSSEIN (US) 2024-12-04 EP claimed
EP-4157451-A1 SUBLINGUAL FORMULATION FOR HYPOTENSION AND SYNCOPE Hamdan, Mohamed Hussein (US) 2023-04-05 EP claimed
US-20210369721-A1 SUBLINGUAL FORMULATION FOR HYPOTENSION AND SYNCOPE HAMDAN MOHAMED HUSSEIN (US) 2021-12-02 US claimed
US-5770221-A HIGH AND LOW MOLECULAR WEIGHT POLYISOBUTYLENE HISAMITSU PHARMACEUTICAL CO., INC. (JP) 1998-06-23 US claimed
US-20250108056-A1 SUBLINGUAL FORMULATION FOR HYPOTENSION AND SYNCOPE HAMDAN MOHAMED HUSSEIN (US) 2025-04-03 US disclosed
EP-4157451-A1 SUBLINGUAL FORMULATION FOR HYPOTENSION AND SYNCOPE Hamdan, Mohamed Hussein (US) 2023-04-05 EP disclosed
US-20210369721-A1 SUBLINGUAL FORMULATION FOR HYPOTENSION AND SYNCOPE HAMDAN MOHAMED HUSSEIN (US) 2021-12-02 US disclosed
EP-0760238-B1 PERCUTANEOUSLY ADMINISTRABLE PREPARATION FOR TREATING URINATION DISORDER HISAMITSU PHARMACEUTICAL CO (JP) 2002-04-17 EP disclosed
US-5770221-A HIGH AND LOW MOLECULAR WEIGHT POLYISOBUTYLENE HISAMITSU PHARMACEUTICAL CO., INC. (JP) 1998-06-23 US disclosed
EP-0760238-A1 PERCUTANEOUSLY ADMINISTRABLE PREPARATION FOR TREATING URINATION DISORDER Hisamitsu Pharmaceutical Co., Inc. (JP) 1997-03-05 EP disclosed